What’s in VASCEPA?
Cardio protection. Proven by science.
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA.
How VASCEPA reduces cardiovascular risk.
VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with heart disease or diabetes and other risk factors. The exact science of how VASCEPA works in your body is not fully understood, but years of clinical testing have led to proven results. Ask your doctor about heart protection with VASCEPA.
VASCEPA is different from fenofibrates and niacin.
- Fenofibrates (TRILIPIX) and niacin (e.g., NIASPAN) are triglyceride-lowering treatments. They are not FDA approved to be used with statins to reduce CV risk, due to lack of CV benefit and more risk of a serious side effect that can lead to muscle breakdown in the body
- It’s important to note that fenofibrates and niacin didn’t show additional CV benefit when used with statins in clinical studies, and were deemed by the FDA to have more risk than benefit when prescribed with statins. The FDA even removed the indication for these products to be used with statins
- The American Diabetes Association also warned against using niacin and fenofibrates with statins, saying that the combination is not generally recommended due to added risks
Fish oil supplements
- After reviewing decades of research, the FDA denied certain medical claims, like lowering blood pressure, for fish oil dietary supplements in 2019
- Contain a mixture of ingredients that may be harmful to heart health, and may have a pronounced fishy smell or require smell masking to hide the signs of deterioration/oxidation (rotting)
- Not intended or approved to treat heart disease
- The American Heart Association advises against self-medicating with supplements
- The most expensive product is one that doesn't treat the intended condition.
- Proven CV benefit in the landmark REDUCE-IT® trial
- Made up of one active ingredient: IPE (icosapent ethyl), an innovative form of EPA
- FDA approved to significantly reduce CV risk in patients taking statins. If you cannot take statins, talk to your doctor about whether or not VASCEPA can help you
- Recognized by medical societies to lower CV risk in patients with heart disease or diabetes and risk factors